Published in Pharmacol Biochem Behav on September 01, 2002
Combination therapies for traumatic brain injury: prospective considerations. J Neurotrauma (2009) 1.67
In-vitro approaches for studying blast-induced traumatic brain injury. J Neurotrauma (2009) 1.23
Resistance to change and vulnerability to stress: autistic-like features of GAP43-deficient mice. Genes Brain Behav (2010) 1.11
Morphine epigenomically regulates behavior through alterations in histone H3 lysine 9 dimethylation in the nucleus accumbens. J Neurosci (2012) 1.07
Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors. Br J Pharmacol (2005) 1.05
Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurotherapeutics (2009) 1.05
Activation of mGluR5 and inhibition of NADPH oxidase improves functional recovery after traumatic brain injury. J Neurotrauma (2013) 0.95
Excitatory synaptic transmission and network activity are depressed following mechanical injury in cortical neurons. J Neurophysiol (2011) 0.94
Primary cultures of astrocytes: their value in understanding astrocytes in health and disease. Neurochem Res (2012) 0.89
Altered calcium signaling following traumatic brain injury. Front Pharmacol (2012) 0.89
Novel neuroinflammatory targets in the chronically injured spinal cord. Neurotherapeutics (2011) 0.87
Fragile X Syndrome and Alzheimer's Disease: Another story about APP and beta-amyloid. Curr Alzheimer Res (2010) 0.87
Metabotropic glutamate receptor-mediated signaling in neuroglia. Wiley Interdiscip Rev Membr Transp Signal (2012) 0.84
mGluR5 knockout mice display increased dendritic spine densities. Neurosci Lett (2012) 0.82
Effects of the mGluR2/3 agonist LY379268 and the mGluR5 antagonist MPEP on handling-induced convulsions during ethanol withdrawal in mice. Alcohol (2008) 0.81
Recent advances in targeting the ionotropic glutamate receptors in treating schizophrenia. Curr Pharm Biotechnol (2012) 0.77
[60]Fullerene derivative modulates adenosine and metabotropic glutamate receptors gene expression: a possible protective effect against hypoxia. J Nanobiotechnology (2014) 0.75
NMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex. Nat Cell Biol (2003) 3.09
The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2. Neuron (2005) 2.68
Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci (2010) 2.40
Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Natl Acad Sci U S A (2005) 2.10
Gene profiling in spinal cord injury shows role of cell cycle in neuronal death. Ann Neurol (2003) 2.06
Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Nat Med (2009) 1.95
Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. CNS Drug Rev (2006) 1.86
Differential tonic GABA conductances in striatal medium spiny neurons. J Neurosci (2008) 1.60
Mossy fiber-CA3 synapses mediate homeostatic plasticity in mature hippocampal neurons. Neuron (2013) 1.57
Cell cycle activation contributes to post-mitotic cell death and secondary damage after spinal cord injury. Brain (2007) 1.56
Cell death mechanisms and modulation in traumatic brain injury. Neurotherapeutics (2010) 1.54
The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration. EMBO J (2006) 1.54
Propofol limits microglial activation after experimental brain trauma through inhibition of nicotinamide adenine dinucleotide phosphate oxidase. Anesthesiology (2013) 1.49
Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states. Neurobiol Aging (2012) 1.41
Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma. J Cereb Blood Flow Metab (2008) 1.41
Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development. Ann Neurol (2012) 1.39
Relationship between availability of NMDA receptor subunits and their expression at the synapse. J Neurosci (2002) 1.33
Role of the cell cycle in the pathobiology of central nervous system trauma. Cell Cycle (2005) 1.32
Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury. J Neuroinflammation (2012) 1.31
Dopamine modulation of GABA tonic conductance in striatal output neurons. J Neurosci (2009) 1.30
Progressive neurodegeneration after experimental brain trauma: association with chronic microglial activation. J Neuropathol Exp Neurol (2014) 1.29
Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity. Glia (2009) 1.28
Expression of distinct alpha subunits of GABAA receptor regulates inhibitory synaptic strength. J Neurophysiol (2004) 1.28
Remodeling of synaptic structures in the motor cortex following spinal cord injury. Exp Neurol (2006) 1.28
Functional excitatory synapses in HEK293 cells expressing neuroligin and glutamate receptors. J Neurophysiol (2003) 1.26
The effects of amyloid precursor protein on postsynaptic composition and activity. J Biol Chem (2009) 1.25
BOK and NOXA are essential mediators of p53-dependent apoptosis. J Biol Chem (2004) 1.25
Gene expression profile changes are commonly modulated across models and species after traumatic brain injury. J Neurotrauma (2003) 1.25
The pathobiology of moderate diffuse traumatic brain injury as identified using a new experimental model of injury in rats. Neurobiol Dis (2004) 1.21
Role of cell cycle proteins in CNS injury. Neurochem Res (2007) 1.21
NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR. J Neurochem (2004) 1.20
Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3beta, and induction of the mitochondrial-dependent intrinsic caspase pathway. Mol Cell Neurosci (2003) 1.20
In vivo and in vitro characterization of novel neuronal plasticity factors identified following spinal cord injury. J Biol Chem (2004) 1.20
Gene expression profiling of experimental traumatic spinal cord injury as a function of distance from impact site and injury severity. Physiol Genomics (2005) 1.19
NMDA receptors increase the size of GABAergic terminals and enhance GABA release. J Neurosci (2005) 1.19
Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma. J Cereb Blood Flow Metab (2011) 1.19
Caspase inhibitor z-DEVD-fmk attenuates calpain and necrotic cell death in vitro and after traumatic brain injury. J Cereb Blood Flow Metab (2004) 1.16
Activation of metabotropic glutamate receptor 5 modulates microglial reactivity and neurotoxicity by inhibiting NADPH oxidase. J Biol Chem (2009) 1.15
The role of the PDZ protein GIPC in regulating NMDA receptor trafficking. J Neurosci (2007) 1.15
Expression of two temporally distinct microglia-related gene clusters after spinal cord injury. Glia (2006) 1.14
Ceramide induces neuronal apoptosis through mitogen-activated protein kinases and causes release of multiple mitochondrial proteins. Mol Cell Neurosci (2005) 1.14
Therapeutic strategies to avoid long-term adverse outcomes of neonatal antiepileptic drug exposure. Epilepsia (2010) 1.13
Apolipoprotein E receptor 2 interactions with the N-methyl-D-aspartate receptor. J Biol Chem (2005) 1.11
Neuronal plasticity after spinal cord injury: identification of a gene cluster driving neurite outgrowth. FASEB J (2004) 1.09
PSD-95 regulates NMDA receptors in developing cerebellar granule neurons of the rat. J Physiol (2003) 1.09
NMDA receptor subtypes at autaptic synapses of cerebellar granule neurons. J Neurophysiol (2006) 1.09
FE65 interaction with the ApoE receptor ApoEr2. J Biol Chem (2006) 1.08
Labeling of dendritic spines with the carbocyanine dye DiI for confocal microscopic imaging in lightly fixed cortical slices. J Neurosci Methods (2007) 1.08
The 4-aminopyridine in vitro epilepsy model analyzed with a perforated multi-electrode array. Neuropharmacology (2010) 1.08
Multiple caspases are activated after traumatic brain injury: evidence for involvement in functional outcome. J Neurotrauma (2002) 1.07
Over-expression of HSP70 attenuates caspase-dependent and caspase-independent pathways and inhibits neuronal apoptosis. J Neurochem (2012) 1.07
Long-lasting NMDA receptor-mediated EPSCs in mouse striatal medium spiny neurons. J Neurophysiol (2007) 1.06
Silent synapses in developing cerebellar granule neurons. J Neurophysiol (2002) 1.06
Cell cycle activation and CNS injury. Neurotox Res (2009) 1.06
Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurotherapeutics (2009) 1.05
Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors. Br J Pharmacol (2005) 1.05
MGLuR5 activation reduces beta-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor. J Neurochem (2004) 1.04
Comparing the predictive value of multiple cognitive, affective, and motor tasks after rodent traumatic brain injury. J Neurotrauma (2012) 1.04
A combined scoring method to assess behavioral recovery after mouse spinal cord injury. Neurosci Res (2010) 1.04
Desensitization and binding properties determine distinct alpha1beta2gamma2 and alpha3beta2gamma2 GABA(A) receptor-channel kinetic behavior. Eur J Neurosci (2007) 1.04
Activation of metabotropic glutamate receptor 5 improves recovery after spinal cord injury in rodents. Ann Neurol (2009) 1.04
Delayed expression of cell cycle proteins contributes to astroglial scar formation and chronic inflammation after rat spinal cord contusion. J Neuroinflammation (2012) 1.02
Excitatory and inhibitory synapses in neuropeptide Y-expressing striatal interneurons. J Neurophysiol (2009) 1.02
CR8, a selective and potent CDK inhibitor, provides neuroprotection in experimental traumatic brain injury. Neurotherapeutics (2012) 1.02
Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity/transmission in the amygdala in a mouse inflammatory pain model. Mol Pain (2010) 1.01
Alpha-synuclein mediates alterations in membrane conductance: a potential role for alpha-synuclein oligomers in cell vulnerability. Eur J Neurosci (2010) 1.01
Delayed inflammatory mRNA and protein expression after spinal cord injury. J Neuroinflammation (2011) 1.01
GABA(A) receptor beta3 subunit deletion decreases alpha2/3 subunits and IPSC duration. J Neurophysiol (2003) 1.01
Fluid-percussion-induced traumatic brain injury model in rats. Nat Protoc (2010) 1.00
The nicotinic receptor in the rat pineal gland is an alpha3beta4 subtype. Mol Pharmacol (2004) 1.00
Therapeutic brain hypothermia, its mechanisms of action, and its prospects as a treatment for epilepsy. Epilepsia (2013) 1.00
SynCAM1 recruits NMDA receptors via protein 4.1B. Mol Cell Neurosci (2009) 0.99
Neuropathological differences between rats and mice after spinal cord injury. J Magn Reson Imaging (2010) 0.98
Distinct roles for somatically and dendritically synthesized brain-derived neurotrophic factor in morphogenesis of dendritic spines. J Neurosci (2013) 0.98
Characterization of inflammatory gene expression and galectin-3 function after spinal cord injury in mice. Brain Res (2012) 0.98
Modulation of ABCA1 by an LXR agonist reduces β-amyloid levels and improves outcome after traumatic brain injury. J Neurotrauma (2011) 0.98
Cell cycle activation and spinal cord injury. Neurotherapeutics (2011) 0.97
Impaired autophagy flux is associated with neuronal cell death after traumatic brain injury. Autophagy (2014) 0.96
Cyclin D1 gene ablation confers neuroprotection in traumatic brain injury. J Neurotrauma (2012) 0.96
Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies. NeuroRx (2004) 0.96
Multifunctional drug treatment in neurotrauma. Neurotherapeutics (2009) 0.96
Deletion of the GABA(A) receptor alpha1 subunit increases tonic GABA(A) receptor current: a role for GABA uptake transporters. J Neurosci (2006) 0.96
Association of NR3A with the N-methyl-D-aspartate receptor NR1 and NR2 subunits. Mol Pharmacol (2002) 0.96
Late exercise reduces neuroinflammation and cognitive dysfunction after traumatic brain injury. Neurobiol Dis (2013) 0.96
Direct and GABA-mediated indirect effects of nicotinic ACh receptor agonists on striatal neurones. J Physiol (2012) 0.95
Activation of mGluR5 and inhibition of NADPH oxidase improves functional recovery after traumatic brain injury. J Neurotrauma (2013) 0.95
Neuroligin-2 accelerates GABAergic synapse maturation in cerebellar granule cells. Mol Cell Neurosci (2009) 0.95
Inhibition of E2F1/CDK1 pathway attenuates neuronal apoptosis in vitro and confers neuroprotection after spinal cord injury in vivo. PLoS One (2012) 0.95
Ceramide-induced cell death in primary neuronal cultures: upregulation of ceramide levels during neuronal apoptosis. J Neurosci Res (2002) 0.93
Axonal α7 nicotinic ACh receptors modulate presynaptic NMDA receptor expression and structural plasticity of glutamatergic presynaptic boutons. Proc Natl Acad Sci U S A (2010) 0.93
Hippocampal neuron firing and local field potentials in the in vitro 4-aminopyridine epilepsy model. J Neurophysiol (2012) 0.92
Deletion of the NR2A subunit prevents developmental changes of NMDA-mEPSCs in cultured mouse cerebellar granule neurones. J Physiol (2005) 0.92
GABA-induced neurite outgrowth of cerebellar granule cells is mediated by GABA(A) receptor activation, calcium influx and CaMKII and erk1/2 pathways. J Neurochem (2003) 0.91
TrkB.T1 contributes to neuropathic pain after spinal cord injury through regulation of cell cycle pathways. J Neurosci (2013) 0.91
GABA(A) Receptor β3 Subunit Expression Regulates Tonic Current in Developing Striatopallidal Medium Spiny Neurons. Front Cell Neurosci (2011) 0.91
Delayed cell cycle pathway modulation facilitates recovery after spinal cord injury. Cell Cycle (2012) 0.90
Developmental changes of GABA synaptic transient in cerebellar granule cells. Mol Pharmacol (2005) 0.90
Differential regulation of the postsynaptic clustering of γ-aminobutyric acid type A (GABAA) receptors by collybistin isoforms. J Biol Chem (2011) 0.90
Altered GABAergic neurotransmission is associated with increased kainate-induced seizure in prostaglandin-endoperoxide synthase-2 deficient mice. Brain Res Bull (2007) 0.90
Termination of epileptiform activity by cooling in rat hippocampal slice epilepsy models. Epilepsy Res (2006) 0.90